Skip to main content
    R

    Research Frontiers Incorporated (REFR)

    Official site

    TECHNOLOGY • ELECTRONIC COMPONENTS • NASDAQ

    $0.34
    +0.02 (+6.95%)

    Market Cap: $10.99M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Research Frontiers Incorporated (REFR) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Research Frontiers (REFR) is expected to report earnings on Mar 3, 2027. In the quarter ended Sep 30, 2026, Research Frontiers reported EPS of -$0.01. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    22%(2/9)
    Avg Surprise
    -42.59%

    Next Report

    REFR has an expected report date of Mar 3, 2027.

    REFR Earnings Call

    The latest REFR earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 9 quarters below that had an estimate, REFR beat 2, missed 5 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $77041, down 78.6% from $359444 a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.01N/AN/AN/AN/AN/AN/AN/ANov 5, 2026$77041
    Jun 30, 2026-$0.02N/AN/AN/AN/AN/AN/AN/AAug 6, 2026$86346
    Mar 31, 2026-$0.02N/AN/AN/AN/AN/AN/AN/AMay 7, 2026$136319
    Dec 31, 2025-$0.02N/AN/AN/AN/AN/AN/AN/AMar 5, 2026$72124
    Sep 30, 2025-$0.01N/AN/AN/AN/AN/AN/AN/ANov 6, 2025$359444
    Jun 30, 2025-$0.02N/AN/AN/AN/AN/AN/AN/AAug 7, 2025$129904
    Mar 31, 2025-$0.01N/AN/AN/AN/AN/AN/AN/AMay 8, 2025$559776
    Dec 31, 2024-$0.02N/AN/AN/AN/AN/AN/AN/AMar 6, 2025$178151
    Sep 30, 2024-$0.01N/AN/AN/AN/AN/AN/AN/ANov 7, 2024$354408
    Jun 30, 2024$0.00N/AN/AN/AN/AN/AN/AN/AAug 1, 2024$489594
    Mar 31, 2024-$0.01N/AN/AN/AN/AN/AN/AN/AMay 9, 2024$313378
    Dec 31, 2023-$0.01N/AN/AN/AN/AN/AN/AN/AMar 7, 2024$312237
    Sep 30, 2023-$0.01N/AN/AN/AN/AN/AN/AN/ANov 2, 2023$164146
    Jun 30, 2023-$0.01N/AN/AN/AN/AN/AN/AN/AAug 3, 2023$185040
    Mar 31, 2023-$0.01N/AN/AN/AN/AN/AN/AN/AMay 4, 2023$248175
    Dec 31, 2022-$0.02N/AN/AN/AN/AN/AN/AN/AMar 9, 2023$129904
    Sep 30, 2022-$0.02N/AN/AN/AN/A-2271.4%N/AN/ANov 3, 2022$150443
    Jun 30, 2022-$0.02N/AN/AN/AN/AN/AN/AN/AAug 4, 2022$85511
    Mar 31, 2022-$0.02N/AN/AN/AN/AN/AN/AN/AMay 5, 2022$173828
    Dec 31, 2021-$0.02N/AN/AN/AN/AN/AN/AN/AMar 9, 2022$212509
    Sep 30, 2021$0.00N/AN/AN/AN/AN/AN/AN/ANov 4, 2021$723465
    Jun 30, 2021-$0.02N/AN/AN/AN/AN/AN/AN/AAug 5, 2021$113937
    Mar 31, 2021-$0.02N/AN/AN/AN/AN/AN/AN/AMay 6, 2021$213123
    Dec 31, 2020-$0.02N/AN/AN/AN/AN/AN/AN/AMar 11, 2021$130536
    Sep 30, 2020-$0.01N/AN/AN/AN/AN/AN/AN/ANov 5, 2020$165628
    Jun 30, 2020-$0.02N/AN/AN/AN/AN/AN/AN/AAug 6, 2020$176113
    Mar 31, 2020-$0.02N/AN/AN/AN/AN/AN/AN/AMay 7, 2020$356173
    Dec 31, 2019-$0.07N/AN/AN/AN/AN/AN/AN/AMar 12, 2020$381463
    Sep 30, 2019-$0.01N/AN/AN/AN/AN/AN/AN/ANov 7, 2019$462869
    Jun 30, 2019-$0.05N/AN/AN/AN/AN/AN/AN/AAug 8, 2019$301035
    Mar 31, 2019-$0.03N/AN/AN/AN/AN/AN/A0 up, 0 downMay 14, 2019$418657
    Dec 31, 2018-$0.02-$0.01N/A-100.00%MissN/AN/AN/AMar 14, 2019$370795
    Sep 30, 2018-$0.03-$0.01N/A-200.00%MissN/AN/AN/ANov 8, 2018$359725
    Jun 30, 2018-$0.02-$0.03-$0.03 - -$0.03+33.33%BeatN/A1N/AAug 13, 2018$324853
    Mar 31, 2018-$0.03-$0.02N/A-50.00%MissN/AN/AN/AMay 14, 2018$433269
    Dec 31, 2017-$0.03-$0.02-$0.02 - -$0.02-50.00%MissN/A1N/AMar 8, 2018$279439
    Sep 30, 2017-$0.01-$0.01N/A0.00%In lineN/AN/A0 up, 0 downNov 2, 2017$488336
    Jun 30, 2017-$0.02-$0.03N/A+33.33%BeatN/AN/AN/AAug 3, 2017$348179
    Mar 31, 2017-$0.04-$0.04N/A0.00%In lineN/AN/AN/AMay 4, 2017$393116
    Dec 31, 2016-$0.06-$0.04N/A-50.00%MissN/AN/AN/AMar 13, 2017$277760
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.06, after -$0.04 the year before. It was -$0.18 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.06N/A
    Dec 31, 2024-$0.04N/A
    Dec 31, 2023-$0.05N/A
    Dec 31, 2022-$0.08N/A
    Dec 31, 2021-$0.06N/A
    Dec 31, 2020-$0.07N/A
    Dec 31, 2019-$0.16N/A
    Dec 31, 2018-$0.10N/A
    Dec 31, 2017-$0.10N/A
    Dec 31, 2016-$0.18N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,600 words across 7 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,6447
    2026Q1Mar 31, 20262,7972
    2025Q4Dec 31, 20256,1555
    2025Q3Sep 30, 20254,8805
    2025Q2Jun 30, 20258,06110
    2025Q1Mar 31, 20255,9473
    2024Q3Sep 30, 20246,0583
    2024Q2Jun 30, 20245,5727

    2026Q3 Earnings Call

    Opening remarks

    Joe Harary President and Chief Executive Officer Thank you, Paul, and good afternoon, everyone, and welcome to Research Frontiers' third quarter 2026 investor conference call. I appreciate you taking the time to join us, and I particularly appreciate the thoughtful questions many of you sent by email in advance. In August, much of our discussion concerned the disruption at Gauzy and the alternatives available to restore SPD film supply. Today, I want to have a different conversation because we have concrete progress to report. Gauzy's court-approved Israeli settlement became effective in September. Additional financings closed in October, and, as Gauzy announced in October, payments have begun flowing to support the restart of SPD emulsion manufacturing in Israel and SPD film manufacturing in Germany. These are important steps that move us along in resuming production and dependable deliveries. To appreciate the significance of these developments, let's go back to our November 6, 2025 investor call, just one year ago. We were reporting increased automotive royalties and growing royalties overall. Research Frontiers had more than $1.1 million in cash, no debt, and an expanding pipeline in automotive, aerospace, architecture, and other markets. We were not discussing a technology in search of a market. We were discussing a technology already selected by leading automakers, proven in aircraft, and attracting interest in new applications. Our focus was on converting development programs into production and expanding royalties. That same week, our architectural retrofit system debuted at GlassBuild in Orlando to strong interest from architects, building owners, and glazing professionals, and we were preparing for major automotive glazing discussions in Detroit. I also was asked to chair the conference and deliver the keynote address at the Detroit Automotive Glazing Summit that month as well. There was genuine commercial momentum. Then, on November 13, 2025, just seven days after our conference call, and just as Gauzy was preparing to give its third quarter 2025 investor conference call, Vision Systems was involuntarily placed into a court-supervised rehabilitation proceeding in France, and the disruption that followed across the Gauzy group struck a critical link in our SPD manufacturing supply chain. That triggered a technical event of default on Gauzy's credit line, which in turn prevented the refinancing to a lower-interest debt facility and choked off Gauzy's liquidity and capital resources. In the space of a week, our conversation changed from how quickly we could build on our momentum to how we could preserve the manufacturing capacity needed to serve our customers. Gauzy hit a brick wall, but it was a financing and manufacturing brick wall, not a rejection of SPD technology by the marketplace. The engineering qualifications, customer relationships, and opportunities that took years to develop did not vanish.

    Frequently Asked Questions About REFR

    When is Research Frontiers's next earnings date?

    Research Frontiers's next earnings report is expected for Mar 3, 2027.

    How often does REFR beat earnings estimates?

    Research Frontiers beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -41.67%.